Smoking cessation new delivery systems, indications may aid quit attempts -- consultant.
This article was originally published in The Tan Sheet
Executive Summary
SMOKING CESSATION PRODUCT NEW DELIVERY SYSTEMS, EXPANDED INDICATIONS may help facilitate and increase consumers' quit attempts, Jack Henningfield, PhD, Pinney Associates, suggested at a Food & Drug Law Institute conference on tobacco dependence at Georgetown University April 9. The current FDA-approved indications for nicotine replacement drugs, such as "aid to smoking cessation," is "so narrow that is limits the focus" and the "appeal" of the OTC products, Henningfield said. The indication "turns people that are interested in action, which is the vast majority of smokers...to `light' cigarettes as their only alternative because they're not ready, willing or able" to attempt quitting, he added.